BioNexus Gene Lab Corp.
BGLC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$709 | -$616 | -$623 | -$348 |
| Dep. & Amort. | $43 | $42 | $40 | $43 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$716 | -$112 | -$311 | $439 |
| Other Non-Cash | $148 | -$51 | $70 | -$188 |
| Operating Cash Flow | -$1,233 | -$738 | -$824 | -$54 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$21 | -$9 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$9 | -$16 | -$16 | -$7 |
| Inv. Sales/Matur. | $1,021 | $0 | $0 | $574 |
| Other Inv. Act. | -$16 | $9 | $9 | -$78 |
| Investing Cash Flow | $990 | -$29 | -$16 | $486 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $34 | -$1 | -$1 | $140 |
| Financing Cash Flow | $34 | -$1 | -$1 | $140 |
| Forex Effect | $44 | $215 | $43 | -$331 |
| Net Chg. in Cash | -$164 | -$552 | -$798 | $240 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,059 | $2,089 | $2,887 | $4,137 |
| End Cash | $2,895 | $1,537 | $2,089 | $4,377 |
| Free Cash Flow | -$1,239 | -$759 | -$833 | -$58 |